• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Brachytherapy

Elekta eyes Turkish radiology market with acquisition of Mesi Medikal

July 24, 2014 By Arezu Sarvestani Leave a Comment

Elekta eyes Turkish radiology market with acquisition of Mesi Medikal

Filed Under: Emerging Markets, Mergers & Acquisitions, News Well, Oncology, Radiosurgery/Radiation therapy Tagged With: Brachytherapy, Elekta, Mesi Medikal

AMIC looks to down-classify brachytherapy’s FDA status

February 24, 2014 By Arezu Sarvestani Leave a Comment

AMIC aims to shift brachytherapy to lower-risk FDA status

Washington-based Advanced Medical Isotope Corp. is evaluating its options for U.S. market approval of its proprietary brachytherapy cancer product, the company announced.

Filed Under: Food & Drug Administration (FDA), News Well, Oncology, Pre-Market Approval (PMA), Radiosurgery/Radiation therapy, Regulatory/Compliance Tagged With: Advanced Medical Isotope Corp., Brachytherapy

Breast cancer: Judge stays C.R. Bard suit against Hologic over Mammosite device

February 7, 2013 By MassDevice staff Leave a Comment

Hologic
C.R. Bard

A federal judge in Delaware put a patent infringement spat between C.R. Bard subsidiary SenoRx and Hologic (NSDQ:HOLX) on hold for 90 days last week.

Filed Under: Legal News, News Well, Patent Infringement, Women's Health Tagged With: Brachytherapy, Breast Cancer, C.R. Bard, Hologic, SenoRx Inc.

iCad soars on Medicare reimbursement nod | Wall Street Beat

November 5, 2012 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

iCad (NSDQ:ICAD) shares nearly doubled their value on Wall Street today after the medical device company said the Centers for Medicare & Medicaid approved a big increase in the reimbursement rate for its Xoft Axxent brachytherapy device.

Filed Under: News Well, Wall Street Beat Tagged With: Abbott, Baxter, Brachytherapy, Cardia Inc., iCad Inc., InspireMD, Neurometrix, Positron Corp., Precision Optics Corp.

Cancer research: Varian awards $100k for radiation therapy registry

November 1, 2012 By MassDevice staff Leave a Comment

Varian Medical Systems logo

Varian Medical Systems (NYSE:VAR), a medical device and software manufacturer focused on radiation-based cancer treatment, awarded a $100,000 grant to the American Board of Radiology Foundation to support a national brachytherapy registry.

Filed Under: News Well, Oncology, Research & Development Tagged With: Brachytherapy, Varian Medical Systems

Elekta Completes the Acquisition of Nucletron

September 15, 2011 By MassDevice Leave a Comment

Elekta AB (publ) (STO:EKTAB) today announced it has successfully
completed its acquisition of Nucletron, the world leader in
brachytherapy treatment planning and delivery. Through the combination
Elekta will offer a complete range of radiotherapy planning and delivery
technologies. As the market leader in Europe and with strong positions
in North America and Asia, Elekta will enhance the combined ability to
meet the clinical needs of cancer patients and health care providers
throughout the world.

“Now we have successfully completed the acquisition and we are very
enthusiastic about building a broader, stronger and highly complementary
range of cutting-edge cancer care solutions”

Filed Under: Mergers & Acquisitions Tagged With: Brachytherapy, Elekta

iCad sued for device acquired in Xoft Inc. acquisition

March 10, 2011 By Dave Price Leave a Comment

iCad, Xoft

Xoft Inc. could turn out to be a lot more expensive for iCad (NSDQ:ICAD) than the $1 million in cash and the 8.47 million shares of stock it paid for the oncology device manufacturer late last year.

Filed Under: Legal News, News Well, Product Liability, Wall Street Beat Tagged With: Brachytherapy, iCad Inc., Xoft Inc.

Theragenics swings to Q4, 2009 black

February 11, 2010 By MassDevice staff Leave a Comment

Theragenics Corp. (NYSE:TGX) posted fourth-quarter sales of $18.7 million for the three months ended Dec. 31, 2009, up 3.2 percent compared with $18.1 million during the same period in 2008. Net income was $389,000, compared with net losses of $62.5 million during Q4 2008:

Press Release

Theragenics® Reports Record Revenue with
2009 Results

$78.3 Million is Highest Annual Revenue in 29-Year History

Filed Under: Business/Financial News, MassDevice Earnings Roundup, News Well Tagged With: Brachytherapy, Theragenics Corp.

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS